Huizhe Wu
0000-0001-7964-1342
Publication & Citation Trends
Publications
0 total
Cuproptosis in cancer: emerging mechanism and therapeutic opportunities.
Cited by 0
Semantic Scholar
Revealing the multiple faces of LRG1: gene expression, structure, function, and therapeutic potential OA
Cited by 1
Semantic Scholar
Novel MAFG-METTL14-SCD1 axis regulates lipid metabolism mediating choroidal melanoma distant metastasis
Cited by 1
Semantic Scholar
NSUNs-driven dysregulation: the next frontier in targeted cancer therapy?
Cited by 0
Semantic Scholar
Short‐chain acyl post‐translational modifications in cancers: Mechanisms, roles, and therapeutic implications
Cited by 40
Semantic Scholar
RBM5 recruiting MGC32805 in a sandwich mode and inducing ΔFAS neoantigen and triggering FAS properties switch: implication in colorectal cancer
Cited by 1
Semantic Scholar
SnoRNAs: The promising targets for anti-tumor therapy OA
Cited by 13
Semantic Scholar
Distinctive tumorigenic significance and innovative oncology targets of SUMOylation OA
Cited by 11
Semantic Scholar
Research Topics
RNA modifications and cancer
(25)
Cancer-related molecular mechanisms research
(21)
MicroRNA in disease regulation
(10)
Epigenetics and DNA Methylation
(10)
RNA Research and Splicing
(9)
Affiliations
Shenyang Pharmaceutical University
Shenyang Medical College
Target (United States)
Chinese Academy of Medical Sciences & Peking Union Medical College
Peking Union Medical College Hospital